4//SEC Filing
Garabedian Christopher Nishan 4
Accession 0001209191-23-031943
CIK 0001785345other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:53 PM ET
Size
5.4 KB
Accession
0001209191-23-031943
Insider Transaction Report
Form 4
Garabedian Christopher Nishan
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-23+18,000→ 18,000 totalExercise: $0.33Exp: 2033-05-22→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest and become exercisable on May 23, 2024, subject to the Reporting Person providing continuous service through such date.
Documents
Issuer
Landos Biopharma, Inc.
CIK 0001785345
Entity typeother
Related Parties
1- filerCIK 0001843665
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 5:53 PM ET
- Size
- 5.4 KB